Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of

Seul Ki Lee1, Won-Hee Jee1, Chan Kwon Jung2

  • 1Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, Republic of Korea.

Plos One
|March 11, 2020
PubMed
Abstract